Fig. 5From: Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle EastBox and whiskers plot for mean EDSS score during the study by time point (FAS). DMT, disease-modifying treatment; EDSS, Expanded Disability Status Scale; FAS, full analysis set. The box plot’s horizontal lines represent the 25th percentile, median and the 75th percentile of the mean EDSS score for top, middle and bottom lines, respectively. The whiskers represent the magnitude from the 10th to the 90th percentiles. The dots on the chart represent mean values across the study period. Outlier values are represented with empty circlesBack to article page